nedaplatin

You have access
Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia
JUNYA HASHIZUME, MADOKA NAMBU, HIROO NAKAGAWA, HITOMI HARASAWA and YUKINOBU KODAMA

Anticancer Research May 2023, 43 (5) 2309-2316; DOI: https://doi.org/10.21873/anticanres.16395
You have access
Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results
YUZURU NIIBE, TAKASHI ONDA, KEITARO MATSUO, YUSUKE INOUE and KAZUSHIGE HAYAKAWA

Anticancer Research December 2017, 37 (12) 6983-6988;
You have access
Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer
SHINSUKE KANEKIYO, SHIGERU TAKEDA, MASAO NAKAJIMA, MITSUO NISHIYAMA, MASAHIRO KITAHARA, YOSHITARO SHINDOU, IIDA MICHIHISA, TOSHIHIRO ABE, SHIGEFUMI YOSHINO, SHOICHI HAZAMA and HIROAKI NAGANO

Anticancer Research April 2016, 36 (4) 1923-1927;
You have access
Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910
KOUZO YAMADA, HARUHIRO SAITO, TETSURO KONDO, SHUJI MURAKAMI, NORIYUKI MASUDA, MICHIKO YAMAMOTO, SATOSHI IGAWA, KEN KATONO, YUICHI TAKIGUCHI, SHUNICHIRO IWASAWA, RYOTA KURIMOTO, HIROAKI OKAMOTO, TSUNEO SHIMOKAWA, YUKIO HOSOMI, YUSUKE TAKAGI, KAZUMA KISHI, MARI OHBA, FUMIHIRO OSHITA and KOSHIRO WATANABE

Anticancer Research December 2015, 35 (12) 6705-6711;
You have access
Phase I Pharmacokinetic Study of S-1 Granules and Nedaplatin for Advanced Head and Neck Cancer
HIDETOSHI HAYASHI, ISAMU OKAMOTO, SHINYA UEDA, KAORU TANAKA, KUNIO OKAMOTO, HISATO KAWAKAMI, SHINICHI NISHINA, MASAYUKI TAKEDA, YASUHITO FUJISAKA, TAROH SATOH, KYOICHI TERAO, YASUMASA NISHIMURA, KATSUMI DOI and KAZUHIKO NAKAGAWA

Anticancer Research December 2013, 33 (12) 5699-5705;

Main menu

User menu

Search

nedaplatin